OCSL Oaktree Specialty Lending | $15.85
+1.9% | 11/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $18.00 -> $18.00 | N/A | View details for Oppenheimer rating of Oaktree Specialty Lending (NASDAQ:OCSL) on 11/22/2024 |
ADSK Autodesk | $321.27
+1.9% | 11/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $350.00 | N/A | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 11/22/2024 |
CATX Perspective Therapeutics | $3.47
+15.7% | 11/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $22.00 -> $16.00 | N/A | View details for Oppenheimer rating of Perspective Therapeutics (NYSE:CATX) on 11/22/2024 |
INTU Intuit | $640.12
-5.7% | 11/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $712.00 -> $722.00 | N/A | View details for Oppenheimer rating of Intuit (NASDAQ:INTU) on 11/22/2024 |
MGRC McGrath RentCorp | $120.90
+1.2% | 11/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $124.00 -> $139.00 | N/A | View details for Oppenheimer rating of McGrath RentCorp (NASDAQ:MGRC) on 11/22/2024 |
DE Deere & Company | $446.65
+2.1% | 11/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $448.00 -> $477.00 | N/A | View details for Oppenheimer rating of Deere & Company (NYSE:DE) on 11/22/2024 |
|
KD Kyndryl | $33.04
+1.7% | 11/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $33.00 -> $37.00 | N/A | View details for Oppenheimer rating of Kyndryl (NYSE:KD) on 11/22/2024 |
ESTC Elastic | $107.94
+14.7% | 11/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $125.00 -> $140.00 | N/A | View details for Oppenheimer rating of Elastic (NYSE:ESTC) on 11/22/2024 |
JACK Jack in the Box | $47.50
-0.6% | 11/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $60.00 | N/A | View details for Oppenheimer rating of Jack in the Box (NASDAQ:JACK) on 11/21/2024 |
NVDA NVIDIA | $141.95
-3.2% | 11/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $175.00 -> $175.00 | N/A | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 11/21/2024 |
PANW Palo Alto Networks | $383.36
-3.6% | 11/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $450.00 -> $450.00 | N/A | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 11/21/2024 |
CRM Salesforce | $342.12
+1.9% | 11/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $330.00 -> $385.00 | N/A | View details for Oppenheimer rating of Salesforce (NYSE:CRM) on 11/21/2024 |
SNOW Snowflake | $167.48
-2.3% | 11/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $180.00 -> $180.00 | N/A | View details for Oppenheimer rating of Snowflake (NYSE:SNOW) on 11/21/2024 |
ARGX argenx | $605.92
+1.5% | 11/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $646.00 -> $675.00 | N/A | View details for Oppenheimer rating of argenx (NASDAQ:ARGX) on 11/21/2024 |
IGIC International General Insurance | $25.98
-0.2% | 11/21/2024 | Initiated by | Oppenheimer | - | Outperform | $30.00 | N/A | View details for Oppenheimer rating of International General Insurance (NASDAQ:IGIC) on 11/21/2024 |
TRU TransUnion | $99.11
+0.5% | 11/20/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $122.00 -> $115.00 | N/A | View details for Oppenheimer rating of TransUnion (NYSE:TRU) on 11/20/2024 |
JPM JPMorgan Chase & Co. | $248.56
+1.6% | 11/20/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | N/A | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 11/20/2024 |
VRT Vertiv | $140.15
-0.9% | 11/19/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $121.00 -> $131.00 | N/A | View details for Oppenheimer rating of Vertiv (NYSE:VRT) on 11/19/2024 |
CLRB Cellectar Biosciences | $1.58
| 11/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $12.00 | N/A | View details for Oppenheimer rating of Cellectar Biosciences (NASDAQ:CLRB) on 11/19/2024 |
EFX Equifax | $253.58
+0.4% | 11/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $315.00 -> $286.00 | N/A | View details for Oppenheimer rating of Equifax (NYSE:EFX) on 11/19/2024 |
GWRE Guidewire Software | $202.77
+1.5% | 11/19/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $220.00 | N/A | View details for Oppenheimer rating of Guidewire Software (NYSE:GWRE) on 11/19/2024 |
INO Inovio Pharmaceuticals | $4.07
+0.2% | 11/18/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $33.00 -> $15.00 | N/A | View details for Oppenheimer rating of Inovio Pharmaceuticals (NASDAQ:INO) on 11/18/2024 |
EVH Evolent Health | $11.25
-3.0% | 11/18/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $34.00 -> $28.00 | N/A | View details for Oppenheimer rating of Evolent Health (NYSE:EVH) on 11/18/2024 |
YMAB Y-mAbs Therapeutics | $10.41
+3.1% | 11/18/2024 | Initiated by | Oppenheimer | - | Outperform | $23.00 | N/A | View details for Oppenheimer rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 11/18/2024 |
ASND Ascendis Pharma A/S | $129.81
+5.8% | 11/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $190.00 -> $180.00 | N/A | View details for Oppenheimer rating of Ascendis Pharma A/S (NASDAQ:ASND) on 11/15/2024 |
CMMB Chemomab Therapeutics | $1.65
+3.1% | 11/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $13.00 -> $11.00 | N/A | View details for Oppenheimer rating of Chemomab Therapeutics (NASDAQ:CMMB) on 11/15/2024 |
JACK Jack in the Box | $47.50
-0.6% | 11/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $60.00 | N/A | View details for Oppenheimer rating of Jack in the Box (NASDAQ:JACK) on 11/15/2024 |
NICE NICE | $176.16
+2.8% | 11/15/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | N/A | View details for Oppenheimer rating of NICE (NASDAQ:NICE) on 11/15/2024 |
TARS Tarsus Pharmaceuticals | $48.24
+4.0% | 11/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $63.00 -> $65.00 | N/A | View details for Oppenheimer rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 11/14/2024 |
ATXS Astria Therapeutics | $9.65
+3.3% | 11/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $26.00 -> $28.00 | N/A | View details for Oppenheimer rating of Astria Therapeutics (NASDAQ:ATXS) on 11/14/2024 |
AIT Applied Industrial Technologies | $277.10
+2.9% | 11/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $260.00 -> $305.00 | N/A | View details for Oppenheimer rating of Applied Industrial Technologies (NYSE:AIT) on 11/14/2024 |
TH Target Hospitality | $8.71
-0.7% | 11/14/2024 | Reiterated by | Oppenheimer | - | Market Perform | | N/A | View details for Oppenheimer rating of Target Hospitality (NASDAQ:TH) on 11/14/2024 |
NVDA NVIDIA | $141.95
-3.2% | 11/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $150.00 -> $175.00 | N/A | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 11/14/2024 |
FRPT Freshpet | $156.76
+0.1% | 11/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $155.00 -> $180.00 | N/A | View details for Oppenheimer rating of Freshpet (NASDAQ:FRPT) on 11/14/2024 |
JEF Jefferies Financial Group | $78.58
+2.4% | 11/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $73.00 -> $83.00 | N/A | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 11/14/2024 |
TPB Turning Point Brands | $62.65
+1.3% | 11/14/2024 | Initiated by | Oppenheimer | - | Outperform | $65.00 | N/A | View details for Oppenheimer rating of Turning Point Brands (NYSE:TPB) on 11/14/2024 |
GWH ESS Tech | $6.00
+15.6% | 11/14/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | N/A | View details for Oppenheimer rating of ESS Tech (NYSE:GWH) on 11/14/2024 |
CRVS Corvus Pharmaceuticals | $8.95
+0.1% | 11/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $8.00 -> $14.00 | N/A | View details for Oppenheimer rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 11/13/2024 |
FLUT Flutter Entertainment | $275.15
+3.2% | 11/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $305.00 | N/A | View details for Oppenheimer rating of Flutter Entertainment (NYSE:FLUT) on 11/13/2024 |
GENI Genius Sports | $9.06
+1.6% | 11/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $12.00 | N/A | View details for Oppenheimer rating of Genius Sports (NYSE:GENI) on 11/13/2024 |
Urgent: Monday is the last day to start collecting up to $4,243 in monthly dividends (Ad) You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors.
Registration to collect your first payout closes this week, so you are advised to sign up today. Click here to find out more and get started. |
CART Maplebear | $43.22
-0.1% | 11/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $60.00 | N/A | View details for Oppenheimer rating of Maplebear (NASDAQ:CART) on 11/13/2024 |
IAS Integral Ad Science | $11.08
-1.1% | 11/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $18.00 | N/A | View details for Oppenheimer rating of Integral Ad Science (NASDAQ:IAS) on 11/13/2024 |
DOX Amdocs | $85.67
+0.6% | 11/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $98.00 -> $105.00 | N/A | View details for Oppenheimer rating of Amdocs (NASDAQ:DOX) on 11/13/2024 |
VVI Viad | $43.27
+0.2% | 11/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $41.00 -> $54.00 | N/A | View details for Oppenheimer rating of Viad (NYSE:VVI) on 11/13/2024 |
EVCM EverCommerce | $11.87
+1.9% | 11/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $13.00 | N/A | View details for Oppenheimer rating of EverCommerce (NASDAQ:EVCM) on 11/13/2024 |
PNR Pentair | $106.91
+0.8% | 11/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $115.00 | N/A | View details for Oppenheimer rating of Pentair (NYSE:PNR) on 11/13/2024 |
NTAP NetApp | $122.34
-3.4% | 11/13/2024 | Initiated by | Oppenheimer | - | Market Perform | | N/A | View details for Oppenheimer rating of NetApp (NASDAQ:NTAP) on 11/13/2024 |
NTNX Nutanix | $73.18
+3.2% | 11/13/2024 | Initiated by | Oppenheimer | - | Outperform | $80.00 | N/A | View details for Oppenheimer rating of Nutanix (NASDAQ:NTNX) on 11/13/2024 |
RBRK Rubrik | $51.19
+4.2% | 11/13/2024 | Initiated by | Oppenheimer | - | Market Perform | | N/A | View details for Oppenheimer rating of Rubrik (NYSE:RBRK) on 11/13/2024 |
PSTG Pure Storage | $51.66
+0.2% | 11/13/2024 | Initiated by | Oppenheimer | - | Outperform | $70.00 | N/A | View details for Oppenheimer rating of Pure Storage (NYSE:PSTG) on 11/13/2024 |
SHOP Shopify | $106.96
+0.5% | 11/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $90.00 -> $130.00 | N/A | View details for Oppenheimer rating of Shopify (NYSE:SHOP) on 11/13/2024 |
CVLT Commvault Systems | $174.60
+2.3% | 11/13/2024 | Initiated by | Oppenheimer | - | Outperform | $200.00 | N/A | View details for Oppenheimer rating of Commvault Systems (NASDAQ:CVLT) on 11/13/2024 |
SONY Sony Group | $19.07
| 11/12/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $108.00 -> $25.00 | N/A | View details for Oppenheimer rating of Sony Group (NYSE:SONY) on 11/12/2024 |
WH Wyndham Hotels & Resorts | $96.66
+0.3% | 11/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $90.00 -> $115.00 | N/A | View details for Oppenheimer rating of Wyndham Hotels & Resorts (NYSE:WH) on 11/12/2024 |
LYV Live Nation Entertainment | $140.26
+1.2% | 11/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $155.00 | N/A | View details for Oppenheimer rating of Live Nation Entertainment (NYSE:LYV) on 11/12/2024 |
RLJ RLJ Lodging Trust | $9.91
+1.1% | 11/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $12.00 | N/A | View details for Oppenheimer rating of RLJ Lodging Trust (NYSE:RLJ) on 11/12/2024 |
ZETA Zeta Global | $22.38
+3.0% | 11/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $33.00 -> $42.00 | N/A | View details for Oppenheimer rating of Zeta Global (NYSE:ZETA) on 11/12/2024 |
AGYS Agilysys | $137.48
+4.2% | 11/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $135.00 | N/A | View details for Oppenheimer rating of Agilysys (NASDAQ:AGYS) on 11/12/2024 |
MPWR Monolithic Power Systems | $580.81
+1.5% | 11/11/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $900.00 -> $900.00 | N/A | View details for Oppenheimer rating of Monolithic Power Systems (NASDAQ:MPWR) on 11/11/2024 |
DNTH Dianthus Therapeutics | $22.34
+10.2% | 11/11/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $52.00 | N/A | View details for Oppenheimer rating of Dianthus Therapeutics (NASDAQ:DNTH) on 11/11/2024 |
PLYA Playa Hotels & Resorts | $9.72
+1.5% | 11/11/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $12.00 | N/A | View details for Oppenheimer rating of Playa Hotels & Resorts (NASDAQ:PLYA) on 11/11/2024 |
NTLA Intellia Therapeutics | $14.30
+3.6% | 11/11/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $60.00 | N/A | View details for Oppenheimer rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/11/2024 |
WMS Advanced Drainage Systems | $131.85
+2.7% | 11/11/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $192.00 -> $184.00 | N/A | View details for Oppenheimer rating of Advanced Drainage Systems (NYSE:WMS) on 11/11/2024 |
CG The Carlyle Group | $53.65
+1.6% | 11/11/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $78.00 -> $85.00 | N/A | View details for Oppenheimer rating of The Carlyle Group (NASDAQ:CG) on 11/11/2024 |
WHF WhiteHorse Finance | $10.54
+0.5% | 11/11/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | $14.00 -> $12.00 | N/A | View details for Oppenheimer rating of WhiteHorse Finance (NASDAQ:WHF) on 11/11/2024 |
ORA Ormat Technologies | $80.74
+0.8% | 11/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $86.00 -> $91.00 | N/A | View details for Oppenheimer rating of Ormat Technologies (NYSE:ORA) on 11/8/2024 |
PINS Pinterest | $30.01
+2.4% | 11/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $40.00 | N/A | View details for Oppenheimer rating of Pinterest (NYSE:PINS) on 11/8/2024 |
ROK Rockwell Automation | $290.78
+4.5% | 11/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $288.00 -> $300.00 | N/A | View details for Oppenheimer rating of Rockwell Automation (NYSE:ROK) on 11/8/2024 |
RUN Sunrun | $10.51
+2.8% | 11/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $22.00 -> $20.00 | N/A | View details for Oppenheimer rating of Sunrun (NASDAQ:RUN) on 11/8/2024 |
SG Sweetgreen | $43.44
+5.3% | 11/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $40.00 -> $45.00 | N/A | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 11/8/2024 |
PNTG The Pennant Group | $31.14
+2.1% | 11/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $34.00 -> $37.00 | N/A | View details for Oppenheimer rating of The Pennant Group (NASDAQ:PNTG) on 11/8/2024 |
TTD Trade Desk | $129.70
+1.8% | 11/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $135.00 | N/A | View details for Oppenheimer rating of Trade Desk (NASDAQ:TTD) on 11/8/2024 |
HEAR Turtle Beach | $15.78
+4.4% | 11/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $20.00 | N/A | View details for Oppenheimer rating of Turtle Beach (NASDAQ:HEAR) on 11/8/2024 |
VTYX Ventyx Biosciences | $1.85
+6.9% | 11/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $9.00 | N/A | View details for Oppenheimer rating of Ventyx Biosciences (NASDAQ:VTYX) on 11/8/2024 |
ALB Albemarle | $108.38
-0.6% | 11/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $171.00 -> $170.00 | N/A | View details for Oppenheimer rating of Albemarle (NYSE:ALB) on 11/8/2024 |
APLE Apple Hospitality REIT | $16.09
+2.2% | 11/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $18.00 | N/A | View details for Oppenheimer rating of Apple Hospitality REIT (NYSE:APLE) on 11/8/2024 |
ARRY Array Technologies | $6.63
+4.7% | 11/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $14.00 | N/A | View details for Oppenheimer rating of Array Technologies (NASDAQ:ARRY) on 11/8/2024 |
AORT Artivion | $28.27
+0.8% | 11/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $30.00 -> $32.00 | N/A | View details for Oppenheimer rating of Artivion (NYSE:AORT) on 11/8/2024 |
BILL BILL | $91.51
+1.7% | 11/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $83.00 | N/A | View details for Oppenheimer rating of BILL (NYSE:BILL) on 11/8/2024 |
CARG CarGurus | $35.62
-0.3% | 11/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $32.00 -> $44.00 | N/A | View details for Oppenheimer rating of CarGurus (NASDAQ:CARG) on 11/8/2024 |
CCSI Consensus Cloud Solutions | $24.49
+3.1% | 11/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $23.00 -> $27.00 | N/A | View details for Oppenheimer rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 11/8/2024 |
CTVA Corteva | $61.23
+0.8% | 11/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $69.00 -> $70.00 | N/A | View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 11/8/2024 |
ESAB ESAB | $127.54
+1.7% | 11/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $138.00 -> $144.00 | N/A | View details for Oppenheimer rating of ESAB (NYSE:ESAB) on 11/8/2024 |
EVH Evolent Health | $11.25
-3.0% | 11/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $34.00 | N/A | View details for Oppenheimer rating of Evolent Health (NYSE:EVH) on 11/8/2024 |
EXPE Expedia Group | $184.92
+0.8% | 11/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $155.00 -> $210.00 | N/A | View details for Oppenheimer rating of Expedia Group (NASDAQ:EXPE) on 11/8/2024 |
HCI HCI Group | $111.50
+1.1% | 11/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $140.00 -> $150.00 | N/A | View details for Oppenheimer rating of HCI Group (NYSE:HCI) on 11/8/2024 |
LGND Ligand Pharmaceuticals | $119.19
+2.3% | 11/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $135.00 -> $147.00 | N/A | View details for Oppenheimer rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 11/8/2024 |
MWA Mueller Water Products | $25.18
+0.8% | 11/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $26.00 -> $27.00 | N/A | View details for Oppenheimer rating of Mueller Water Products (NYSE:MWA) on 11/8/2024 |
PMVP PMV Pharmaceuticals | $1.61
| 11/8/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $6.00 | N/A | View details for Oppenheimer rating of PMV Pharmaceuticals (NASDAQ:PMVP) on 11/8/2024 |
CWAN Clearwater Analytics | $31.91
+0.5% | 11/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $31.00 -> $35.00 | N/A | View details for Oppenheimer rating of Clearwater Analytics (NYSE:CWAN) on 11/7/2024 |
Urgent: Monday is the last day to start collecting up to $4,243 in monthly dividends (Ad) You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors.
Registration to collect your first payout closes this week, so you are advised to sign up today. Click here to find out more and get started. |
GILD Gilead Sciences | $90.19
+0.5% | 11/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $105.00 | N/A | View details for Oppenheimer rating of Gilead Sciences (NASDAQ:GILD) on 11/7/2024 |
HUBS HubSpot | $742.74
+3.2% | 11/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $625.00 -> $740.00 | N/A | View details for Oppenheimer rating of HubSpot (NYSE:HUBS) on 11/7/2024 |
APP AppLovin | $333.31
+4.7% | 11/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $180.00 -> $260.00 | N/A | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 11/7/2024 |
TTWO Take-Two Interactive Software | $188.15
+0.8% | 11/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $190.00 | N/A | View details for Oppenheimer rating of Take-Two Interactive Software (NASDAQ:TTWO) on 11/7/2024 |
JCI Johnson Controls International | $83.45
-0.6% | 11/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $86.00 -> $87.00 | N/A | View details for Oppenheimer rating of Johnson Controls International (NYSE:JCI) on 11/7/2024 |
VECO Veeco Instruments | $27.40
+3.2% | 11/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $40.00 | N/A | View details for Oppenheimer rating of Veeco Instruments (NASDAQ:VECO) on 11/7/2024 |
ML MoneyLion | $87.00
+8.4% | 11/7/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $80.00 | N/A | View details for Oppenheimer rating of MoneyLion (NYSE:ML) on 11/7/2024 |
SGHC Super Group | $6.08
+2.5% | 11/7/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $6.00 | N/A | View details for Oppenheimer rating of Super Group (NYSE:SGHC) on 11/7/2024 |
REGN Regeneron Pharmaceuticals | $738.00
-0.9% | 11/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $1,150.00 -> $1,000.00 | N/A | View details for Oppenheimer rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 11/6/2024 |
CART Maplebear | $43.22
-0.1% | 11/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $55.00 | N/A | View details for Oppenheimer rating of Maplebear (NASDAQ:CART) on 11/6/2024 |
AGCO AGCO | $98.41
+1.0% | 11/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $131.00 -> $111.00 | N/A | View details for Oppenheimer rating of AGCO (NYSE:AGCO) on 11/6/2024 |
TKR Timken | $75.96
+1.0% | 11/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $102.00 -> $97.00 | N/A | View details for Oppenheimer rating of Timken (NYSE:TKR) on 11/6/2024 |
APLS Apellis Pharmaceuticals | $30.77
+10.9% | 11/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $40.00 | N/A | View details for Oppenheimer rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 11/6/2024 |
INGR Ingredion | $146.47
+1.5% | 11/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $147.00 -> $178.00 | N/A | View details for Oppenheimer rating of Ingredion (NYSE:INGR) on 11/6/2024 |
TRDA Entrada Therapeutics | $18.80
+4.2% | 11/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $28.00 | N/A | View details for Oppenheimer rating of Entrada Therapeutics (NASDAQ:TRDA) on 11/6/2024 |
VERU Veru | $0.68
+8.0% | 11/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $5.00 -> $5.00 | N/A | View details for Oppenheimer rating of Veru (NASDAQ:VERU) on 11/5/2024 |
NXPI NXP Semiconductors | $226.38
+0.8% | 11/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $330.00 -> $300.00 | N/A | View details for Oppenheimer rating of NXP Semiconductors (NASDAQ:NXPI) on 11/6/2024 |
BAC Bank of America | $47.00
+1.2% | 11/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $56.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 11/5/2024 |
C Citigroup | $69.84
+1.3% | 11/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $91.00 -> $107.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 11/5/2024 |
CTOS Custom Truck One Source | $5.72
+9.0% | 11/5/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $6.00 -> $5.00 | Low | View details for Oppenheimer rating of Custom Truck One Source (NYSE:CTOS) on 11/5/2024 |
GS The Goldman Sachs Group | $602.75
+1.1% | 11/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $614.00 -> $661.00 | High | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 11/5/2024 |
JPM JPMorgan Chase & Co. | $248.56
+1.6% | 11/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $232.00 -> $241.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 11/5/2024 |
JEF Jefferies Financial Group | $78.58
+2.4% | 11/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $71.00 -> $73.00 | Low | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 11/5/2024 |
ST Sensata Technologies | $31.89
+3.3% | 11/5/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $47.00 -> $44.00 | Medium | View details for Oppenheimer rating of Sensata Technologies (NYSE:ST) on 11/5/2024 |
USB U.S. Bancorp | $52.48
+2.1% | 11/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $59.00 -> $64.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 11/5/2024 |
WM Waste Management | $224.41
+1.3% | 11/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $230.00 -> $231.00 | Low | View details for Oppenheimer rating of Waste Management (NYSE:WM) on 11/5/2024 |
TCMD Tactile Systems Technology | $17.85
+12.0% | 11/5/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | High | View details for Oppenheimer rating of Tactile Systems Technology (NASDAQ:TCMD) on 11/5/2024 |
EPIX ESSA Pharma | $1.83
+4.0% | 11/4/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | High | View details for Oppenheimer rating of ESSA Pharma (NASDAQ:EPIX) on 11/4/2024 |
APTV Aptiv | $54.38
+1.9% | 11/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $147.00 -> $83.00 | Low | View details for Oppenheimer rating of Aptiv (NYSE:APTV) on 11/1/2024 |
COMP Compass | $6.83
+1.3% | 11/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $8.00 -> $8.50 | Medium | View details for Oppenheimer rating of Compass (NYSE:COMP) on 11/1/2024 |
ITRI Itron | $118.93
+2.2% | 11/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $124.00 | Low | View details for Oppenheimer rating of Itron (NASDAQ:ITRI) on 11/1/2024 |
LMAT LeMaitre Vascular | $107.97
+2.0% | 11/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $90.00 -> $93.00 | High | View details for Oppenheimer rating of LeMaitre Vascular (NASDAQ:LMAT) on 11/1/2024 |
WCC WESCO International | $209.86
+1.2% | 11/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $205.00 -> $225.00 | Medium | View details for Oppenheimer rating of WESCO International (NYSE:WCC) on 11/1/2024 |
AMZN Amazon.com | $197.12
-0.6% | 11/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $220.00 -> $230.00 | Medium | View details for Oppenheimer rating of Amazon.com (NASDAQ:AMZN) on 11/1/2024 |
TEAM Atlassian | $260.58
+2.6% | 11/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $230.00 -> $270.00 | High | View details for Oppenheimer rating of Atlassian (NASDAQ:TEAM) on 11/1/2024 |
THG The Hanover Insurance Group | $163.60
+0.5% | 11/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $165.00 -> $177.00 | Medium | View details for Oppenheimer rating of The Hanover Insurance Group (NYSE:THG) on 11/1/2024 |
ARGX argenx | $605.92
+1.5% | 11/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $560.00 -> $646.00 | Low | View details for Oppenheimer rating of argenx (NASDAQ:ARGX) on 11/1/2024 |
TREE LendingTree | $43.99
+0.8% | 11/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $70.00 | High | View details for Oppenheimer rating of LendingTree (NASDAQ:TREE) on 11/1/2024 |
ONTO Onto Innovation | $166.25
-0.2% | 11/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $260.00 -> $275.00 | High | View details for Oppenheimer rating of Onto Innovation (NYSE:ONTO) on 11/1/2024 |
PRAX Praxis Precision Medicines | $74.50
+2.0% | 10/31/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $143.00 -> $163.00 | Low | View details for Oppenheimer rating of Praxis Precision Medicines (NASDAQ:PRAX) on 10/31/2024 |
UTHR United Therapeutics | $372.89
+1.5% | 10/31/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $575.00 -> $600.00 | Low | View details for Oppenheimer rating of United Therapeutics (NASDAQ:UTHR) on 10/31/2024 |
BIIB Biogen | $157.90
-0.1% | 10/31/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $270.00 -> $255.00 | High | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 10/31/2024 |
BKNG Booking | $5,177.15
-0.6% | 10/31/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $5,000.00 -> $5,500.00 | Low | View details for Oppenheimer rating of Booking (NASDAQ:BKNG) on 10/31/2024 |
TWLO Twilio | $104.37
+2.3% | 10/31/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $90.00 | High | View details for Oppenheimer rating of Twilio (NYSE:TWLO) on 10/31/2024 |
OLED Universal Display | $168.41
+0.8% | 10/31/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $240.00 -> $220.00 | Medium | View details for Oppenheimer rating of Universal Display (NASDAQ:OLED) on 10/31/2024 |
MOD Modine Manufacturing | $143.22
+1.9% | 10/31/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $144.00 -> $145.00 | Low | View details for Oppenheimer rating of Modine Manufacturing (NYSE:MOD) on 10/31/2024 |
AVDL Avadel Pharmaceuticals | $11.66
| 10/31/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $29.00 -> $30.00 | High | View details for Oppenheimer rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 10/31/2024 |
ARVN Arvinas | $25.86
+3.0% | 10/31/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $40.00 | Medium | View details for Oppenheimer rating of Arvinas (NASDAQ:ARVN) on 10/31/2024 |
TERN Terns Pharmaceuticals | $5.79
+1.4% | 10/31/2024 | Initiated by | Oppenheimer | - | Outperform | $82.00 | High | View details for Oppenheimer rating of Terns Pharmaceuticals (NASDAQ:TERN) on 10/31/2024 |
KLAC KLA | $639.55
+1.0% | 10/31/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $750.00 -> $850.00 | High | View details for Oppenheimer rating of KLA (NASDAQ:KLAC) on 10/31/2024 |
Urgent: Monday is the last day to start collecting up to $4,243 in monthly dividends (Ad) You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors.
Registration to collect your first payout closes this week, so you are advised to sign up today. Click here to find out more and get started. |
ALSN Allison Transmission | $119.66
+1.3% | 10/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $90.00 -> $115.00 | High | View details for Oppenheimer rating of Allison Transmission (NYSE:ALSN) on 10/30/2024 |
GOOG Alphabet | $166.57
-1.6% | 10/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $215.00 | High | View details for Oppenheimer rating of Alphabet (NASDAQ:GOOG) on 10/30/2024 |
ATRC AtriCure | $35.74
+0.1% | 10/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $32.00 -> $36.00 | High | View details for Oppenheimer rating of AtriCure (NASDAQ:ATRC) on 10/30/2024 |
GLW Corning | $48.50
+1.4% | 10/30/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $51.00 -> $58.00 | Medium | View details for Oppenheimer rating of Corning (NYSE:GLW) on 10/30/2024 |
ESAB ESAB | $127.54
+1.7% | 10/30/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $122.00 -> $138.00 | Medium | View details for Oppenheimer rating of ESAB (NYSE:ESAB) on 10/30/2024 |
HRMY Harmony Biosciences | $34.07
+2.5% | 10/30/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $56.00 -> $59.00 | High | View details for Oppenheimer rating of Harmony Biosciences (NASDAQ:HRMY) on 10/30/2024 |
INCY Incyte | $71.72
+1.9% | 10/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $81.00 -> $82.00 | Medium | View details for Oppenheimer rating of Incyte (NASDAQ:INCY) on 10/30/2024 |
RSG Republic Services | $216.79
+1.3% | 10/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $219.00 -> $220.00 | High | View details for Oppenheimer rating of Republic Services (NYSE:RSG) on 10/30/2024 |
SAGE Sage Therapeutics | $5.17
+6.6% | 10/30/2024 | Target Lowered by | Oppenheimer | - | Market Perform -> Market Perform | $9.00 -> $8.00 | High | View details for Oppenheimer rating of Sage Therapeutics (NASDAQ:SAGE) on 10/30/2024 |
TRNS Transcat | $109.02
+2.1% | 10/30/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $155.00 -> $130.00 | Medium | View details for Oppenheimer rating of Transcat (NASDAQ:TRNS) on 10/30/2024 |
VRTX Vertex Pharmaceuticals | $450.97
+0.1% | 10/30/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $550.00 -> $540.00 | Low | View details for Oppenheimer rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 10/30/2024 |
V Visa | $309.93
+0.0% | 10/30/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $318.00 -> $321.00 | Medium | View details for Oppenheimer rating of Visa (NYSE:V) on 10/30/2024 |
WM Waste Management | $224.41
+1.3% | 10/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $224.00 -> $230.00 | Medium | View details for Oppenheimer rating of Waste Management (NYSE:WM) on 10/30/2024 |
BLDR Builders FirstSource | $178.52
+1.5% | 10/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $225.00 -> $225.00 | Low | View details for Oppenheimer rating of Builders FirstSource (NYSE:BLDR) on 10/29/2024 |
IDYA IDEAYA Biosciences | $26.79
+0.7% | 10/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $53.00 -> $53.00 | Medium | View details for Oppenheimer rating of IDEAYA Biosciences (NASDAQ:IDYA) on 10/29/2024 |
TMDX TransMedics Group | $76.04
-4.2% | 10/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $125.00 | High | View details for Oppenheimer rating of TransMedics Group (NASDAQ:TMDX) on 10/29/2024 |
SHAK Shake Shack | $122.97
+0.4% | 10/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $122.00 -> $135.00 | High | View details for Oppenheimer rating of Shake Shack (NYSE:SHAK) on 10/28/2024 |
SLNO Soleno Therapeutics | $57.78
+5.8% | 10/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $73.00 | Low | View details for Oppenheimer rating of Soleno Therapeutics (NASDAQ:SLNO) on 10/28/2024 |
PHAR Pharming Group | $7.53
-3.0% | 10/28/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $31.00 -> $30.00 | Low | View details for Oppenheimer rating of Pharming Group (NASDAQ:PHAR) on 10/28/2024 |
RVMD Revolution Medicines | $56.75
-0.1% | 10/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $60.00 | Low | View details for Oppenheimer rating of Revolution Medicines (NASDAQ:RVMD) on 10/28/2024 |
POOL Pool | $366.49
+0.6% | 10/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $380.00 -> $386.00 | Low | View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 10/28/2024 |
HCA HCA Healthcare | $324.92
-2.2% | 10/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $390.00 -> $400.00 | Medium | View details for Oppenheimer rating of HCA Healthcare (NYSE:HCA) on 10/28/2024 |
UPS United Parcel Service | $134.82
+2.6% | 10/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $140.00 -> $146.00 | Medium | View details for Oppenheimer rating of United Parcel Service (NYSE:UPS) on 10/28/2024 |
AIT Applied Industrial Technologies | $277.10
+2.9% | 10/25/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $235.00 -> $260.00 | Low | View details for Oppenheimer rating of Applied Industrial Technologies (NYSE:AIT) on 10/25/2024 |
BKNG Booking | $5,177.15
-0.6% | 10/25/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $4,200.00 -> $5,000.00 | Low | View details for Oppenheimer rating of Booking (NASDAQ:BKNG) on 10/25/2024 |
DXCM DexCom | $72.83
-2.2% | 10/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $115.00 -> $105.00 | High | View details for Oppenheimer rating of DexCom (NASDAQ:DXCM) on 10/25/2024 |
MGRC McGrath RentCorp | $120.90
+1.2% | 10/25/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $124.00 | High | View details for Oppenheimer rating of McGrath RentCorp (NASDAQ:MGRC) on 10/25/2024 |
NDAQ Nasdaq | $81.07
+0.2% | 10/25/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $84.00 -> $86.00 | Low | View details for Oppenheimer rating of Nasdaq (NASDAQ:NDAQ) on 10/25/2024 |
ENSG The Ensign Group | $146.36
-0.7% | 10/25/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $165.00 -> $168.00 | Medium | View details for Oppenheimer rating of The Ensign Group (NASDAQ:ENSG) on 10/25/2024 |
TPH Tri Pointe Homes | $42.62
+1.5% | 10/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $56.00 -> $53.00 | High | View details for Oppenheimer rating of Tri Pointe Homes (NYSE:TPH) on 10/25/2024 |
TYL Tyler Technologies | $609.09
+2.0% | 10/25/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $625.00 -> $700.00 | Low | View details for Oppenheimer rating of Tyler Technologies (NYSE:TYL) on 10/25/2024 |
T AT&T | $23.18
+0.9% | 10/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $23.00 -> $24.00 | Low | View details for Oppenheimer rating of AT&T (NYSE:T) on 10/24/2024 |
CME CME Group | $229.04
+1.1% | 10/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $245.00 -> $258.00 | Low | View details for Oppenheimer rating of CME Group (NASDAQ:CME) on 10/24/2024 |
PRO PROS | $23.90
+1.1% | 10/24/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $31.00 -> $27.00 | Low | View details for Oppenheimer rating of PROS (NYSE:PRO) on 10/24/2024 |
SEIC SEI Investments | $80.82
+0.8% | 10/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $81.00 -> $85.00 | Low | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 10/24/2024 |
CRM Salesforce | $342.12
+1.9% | 10/24/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $330.00 | Low | View details for Oppenheimer rating of Salesforce (NYSE:CRM) on 10/24/2024 |
SPT Sprout Social | $32.10
+5.9% | 10/24/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $43.00 -> $40.00 | High | View details for Oppenheimer rating of Sprout Social (NASDAQ:SPT) on 10/24/2024 |
TMUS T-Mobile US | $238.28
+0.7% | 10/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $215.00 -> $250.00 | High | View details for Oppenheimer rating of T-Mobile US (NASDAQ:TMUS) on 10/24/2024 |
TRU TransUnion | $99.11
+0.5% | 10/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $118.00 -> $122.00 | Medium | View details for Oppenheimer rating of TransUnion (NYSE:TRU) on 10/24/2024 |
VRT Vertiv | $140.15
-0.9% | 10/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $115.00 -> $121.00 | Low | View details for Oppenheimer rating of Vertiv (NYSE:VRT) on 10/24/2024 |
ZETA Zeta Global | $22.38
+3.0% | 10/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $29.00 -> $33.00 | Low | View details for Oppenheimer rating of Zeta Global (NYSE:ZETA) on 10/24/2024 |
GB Global Blue Group | $5.96
-4.6% | 10/24/2024 | Initiated by | Oppenheimer | - | Outperform | $6.00 | High | View details for Oppenheimer rating of Global Blue Group (NYSE:GB) on 10/24/2024 |
FERG Ferguson | $208.92
+1.2% | 10/23/2024 | Initiated by | Oppenheimer | - | Outperform | $234.00 | Low | View details for Oppenheimer rating of Ferguson (NASDAQ:FERG) on 10/23/2024 |
ENPH Enphase Energy | $66.29
+4.3% | 10/23/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $134.00 -> $101.00 | High | View details for Oppenheimer rating of Enphase Energy (NASDAQ:ENPH) on 10/23/2024 |
MDGL Madrigal Pharmaceuticals | $347.45
+5.5% | 10/23/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $375.00 -> $350.00 | Medium | View details for Oppenheimer rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 10/23/2024 |
APP AppLovin | $333.31
+4.7% | 10/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $105.00 -> $180.00 | Low | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 10/23/2024 |
DENN Denny's | $6.25
-2.2% | 10/23/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $7.00 | Medium | View details for Oppenheimer rating of Denny’s (NASDAQ:DENN) on 10/23/2024 |
PHM PulteGroup | $129.76
+1.3% | 10/23/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $168.00 -> $165.00 | Low | View details for Oppenheimer rating of PulteGroup (NYSE:PHM) on 10/23/2024 |
MCO Moody's | $480.66
+0.8% | 10/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $536.00 -> $543.00 | Low | View details for Oppenheimer rating of Moody’s (NYSE:MCO) on 10/23/2024 |
CSL Carlisle Companies | $449.72
+1.9% | 10/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $480.00 -> $505.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 10/22/2024 |
Urgent: Monday is the last day to start collecting up to $4,243 in monthly dividends (Ad) You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors.
Registration to collect your first payout closes this week, so you are advised to sign up today. Click here to find out more and get started. |
CYBR CyberArk Software | $319.73
-2.9% | 10/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $310.00 -> $360.00 | Low | View details for Oppenheimer rating of CyberArk Software (NASDAQ:CYBR) on 10/22/2024 |
ESAB ESAB | $127.54
+1.7% | 10/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $115.00 -> $122.00 | Low | View details for Oppenheimer rating of ESAB (NYSE:ESAB) on 10/22/2024 |
PANW Palo Alto Networks | $383.36
-3.6% | 10/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $410.00 -> $450.00 | Low | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 10/22/2024 |
PNR Pentair | $106.91
+0.8% | 10/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $98.00 -> $110.00 | Low | View details for Oppenheimer rating of Pentair (NYSE:PNR) on 10/22/2024 |
PRGS Progress Software | $69.25
+0.8% | 10/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $80.00 | Low | View details for Oppenheimer rating of Progress Software (NASDAQ:PRGS) on 10/22/2024 |
TWLO Twilio | $104.37
+2.3% | 10/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $85.00 | Low | View details for Oppenheimer rating of Twilio (NYSE:TWLO) on 10/22/2024 |
ZWS Zurn Elkay Water Solutions | $39.93
+1.5% | 10/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $37.00 -> $40.00 | Low | View details for Oppenheimer rating of Zurn Elkay Water Solutions (NYSE:ZWS) on 10/22/2024 |
MNDY monday.com | $284.59
+3.0% | 10/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $275.00 -> $325.00 | Low | View details for Oppenheimer rating of monday.com (NASDAQ:MNDY) on 10/22/2024 |
QSR Restaurant Brands International | $69.09
-1.0% | 10/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $89.00 -> $86.00 | Medium | View details for Oppenheimer rating of Restaurant Brands International (NYSE:QSR) on 10/22/2024 |
CLH Clean Harbors | $252.46
+1.0% | 10/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $252.00 -> $270.00 | Low | View details for Oppenheimer rating of Clean Harbors (NYSE:CLH) on 10/21/2024 |
INGR Ingredion | $146.47
+1.5% | 10/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $138.00 -> $147.00 | Low | View details for Oppenheimer rating of Ingredion (NYSE:INGR) on 10/21/2024 |
KNF Knife River | $102.65
+2.1% | 10/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $110.00 | Low | View details for Oppenheimer rating of Knife River (NYSE:KNF) on 10/21/2024 |
LVRO Lavoro | $5.09
+4.9% | 10/21/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $9.00 -> $7.00 | High | View details for Oppenheimer rating of Lavoro (NASDAQ:LVRO) on 10/21/2024 |
RSG Republic Services | $216.79
+1.3% | 10/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $210.00 -> $219.00 | Low | View details for Oppenheimer rating of Republic Services (NYSE:RSG) on 10/21/2024 |
WCN Waste Connections | $189.85
+0.4% | 10/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $191.00 -> $194.00 | Low | View details for Oppenheimer rating of Waste Connections (NYSE:WCN) on 10/21/2024 |
BIOX Bioceres Crop Solutions | $6.13
-4.8% | 10/21/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $16.00 -> $13.00 | Low | View details for Oppenheimer rating of Bioceres Crop Solutions (NASDAQ:BIOX) on 10/21/2024 |
ISRG Intuitive Surgical | $547.87
-0.5% | 10/18/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Intuitive Surgical (NASDAQ:ISRG) on 10/18/2024 |
U Unity Software | $23.51
+4.7% | 10/18/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Unity Software (NYSE:U) on 10/18/2024 |
NFLX Netflix | $897.79
+0.0% | 10/17/2024 | Target Set by | Oppenheimer | Analyst Jason Helfstein | | $775.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 10/17/2024 |
NFLX Netflix | $897.79
+0.0% | 10/18/2024 | Target Raised by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $775.00 -> $825.00 | High | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 10/18/2024 |
NOW ServiceNow | $1,060.57
+1.3% | 10/17/2024 | Target Raised by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $825.00 -> $1,020.00 | Low | View details for Oppenheimer rating of ServiceNow (NYSE:NOW) on 10/17/2024 |
USB U.S. Bancorp | $52.48
+2.1% | 10/17/2024 | Target Raised by | Oppenheimer | Analyst Chris Kotowski | Outperform -> Outperform | $57.00 -> $59.00 | Medium | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 10/17/2024 |
GWW W.W. Grainger | $1,206.65
+1.0% | 10/17/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of W.W. Grainger (NYSE:GWW) on 10/17/2024 |
LFUS Littelfuse | $243.82
+2.2% | 10/17/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $310.00 | Medium | View details for Oppenheimer rating of Littelfuse (NASDAQ:LFUS) on 10/17/2024 |
ULTA Ulta Beauty | $338.38
-0.1% | 10/16/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $435.00 -> $435.00 | High | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 10/16/2024 |
KKR KKR & Co. Inc. | $158.58
+0.6% | 10/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $128.00 -> $148.00 | Low | View details for Oppenheimer rating of KKR & Co. Inc. (NYSE:KKR) on 10/16/2024 |
STEP StepStone Group | $67.05
+1.6% | 10/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $56.00 -> $73.00 | High | View details for Oppenheimer rating of StepStone Group (NASDAQ:STEP) on 10/16/2024 |
URGN UroGen Pharma | $11.91
+3.1% | 10/16/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $40.00 -> $40.00 | High | View details for Oppenheimer rating of UroGen Pharma (NASDAQ:URGN) on 10/16/2024 |
BAC Bank of America | $47.00
+1.2% | 10/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $49.00 -> $50.00 | Medium | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 10/16/2024 |
OWL Blue Owl Capital | $24.55
+0.9% | 10/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $21.00 -> $24.00 | Medium | View details for Oppenheimer rating of Blue Owl Capital (NYSE:OWL) on 10/16/2024 |
CG The Carlyle Group | $53.65
+1.6% | 10/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $64.00 -> $78.00 | Medium | View details for Oppenheimer rating of The Carlyle Group (NASDAQ:CG) on 10/16/2024 |
C Citigroup | $69.84
+1.3% | 10/16/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $92.00 -> $91.00 | Medium | View details for Oppenheimer rating of Citigroup (NYSE:C) on 10/16/2024 |
DOV Dover | $204.70
+1.1% | 10/16/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $210.00 -> $215.00 | Low | View details for Oppenheimer rating of Dover (NYSE:DOV) on 10/16/2024 |
GCMG GCM Grosvenor | $12.33
+0.7% | 10/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $18.00 | High | View details for Oppenheimer rating of GCM Grosvenor (NASDAQ:GCMG) on 10/16/2024 |
GS The Goldman Sachs Group | $602.75
+1.1% | 10/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $577.00 -> $614.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 10/16/2024 |
RLI RLI | $177.94
-0.1% | 10/16/2024 | Initiated by | Oppenheimer | - | Market Perform | | Medium | View details for Oppenheimer rating of RLI (NYSE:RLI) on 10/16/2024 |
LRMR Larimar Therapeutics | $6.16
+0.5% | 10/16/2024 | Initiated by | Oppenheimer | - | Outperform | $26.00 | High | View details for Oppenheimer rating of Larimar Therapeutics (NASDAQ:LRMR) on 10/16/2024 |
BNTC Benitec Biopharma | $10.49
+2.8% | 10/16/2024 | Initiated by | Oppenheimer | - | Outperform | $35.00 | Low | View details for Oppenheimer rating of Benitec Biopharma (NASDAQ:BNTC) on 10/16/2024 |
ZBH Zimmer Biomet | $110.23
+1.7% | 10/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $145.00 -> $135.00 | Low | View details for Oppenheimer rating of Zimmer Biomet (NYSE:ZBH) on 10/15/2024 |
FUN Cedar Fair | $45.40
+0.2% | 10/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $67.00 -> $60.00 | Low | View details for Oppenheimer rating of Cedar Fair (NYSE:FUN) on 10/15/2024 |
NDAQ Nasdaq | $81.07
+0.2% | 10/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $80.00 -> $84.00 | Low | View details for Oppenheimer rating of Nasdaq (NASDAQ:NDAQ) on 10/14/2024 |
ROK Rockwell Automation | $290.78
+4.5% | 10/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $270.00 -> $288.00 | Low | View details for Oppenheimer rating of Rockwell Automation (NYSE:ROK) on 10/14/2024 |
VRT Vertiv | $140.15
-0.9% | 10/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $100.00 -> $115.00 | Low | View details for Oppenheimer rating of Vertiv (NYSE:VRT) on 10/14/2024 |
AVNT Avient | $52.28
+2.2% | 10/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $53.00 -> $58.00 | High | View details for Oppenheimer rating of Avient (NYSE:AVNT) on 10/14/2024 |
CME CME Group | $229.04
+1.1% | 10/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $228.00 -> $245.00 | Low | View details for Oppenheimer rating of CME Group (NASDAQ:CME) on 10/14/2024 |
JPM JPMorgan Chase & Co. | $248.56
+1.6% | 10/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $234.00 -> $232.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 10/14/2024 |
MOD Modine Manufacturing | $143.22
+1.9% | 10/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $135.00 -> $144.00 | Medium | View details for Oppenheimer rating of Modine Manufacturing (NYSE:MOD) on 10/14/2024 |
WMT Walmart | $90.44
+2.3% | 10/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $81.00 -> $90.00 | Low | View details for Oppenheimer rating of Walmart (NYSE:WMT) on 10/14/2024 |
CLRB Cellectar Biosciences | $1.58
| 10/11/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $14.00 | Low | View details for Oppenheimer rating of Cellectar Biosciences (NASDAQ:CLRB) on 10/11/2024 |
CATX Perspective Therapeutics | $3.47
+15.7% | 10/11/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $22.00 -> $22.00 | High | View details for Oppenheimer rating of Perspective Therapeutics (NYSE:CATX) on 10/11/2024 |
GWRE Guidewire Software | $202.77
+1.5% | 10/11/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $200.00 | Medium | View details for Oppenheimer rating of Guidewire Software (NYSE:GWRE) on 10/11/2024 |
DPZ Domino's Pizza | $452.81
+1.6% | 10/11/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $490.00 -> $490.00 | Low | View details for Oppenheimer rating of Domino’s Pizza (NYSE:DPZ) on 10/11/2024 |
SAR Saratoga Investment | $26.07
+1.5% | 10/10/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $23.00 -> $25.00 | Low | View details for Oppenheimer rating of Saratoga Investment (NYSE:SAR) on 10/10/2024 |
NFLX Netflix | $897.79
+0.0% | 10/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $725.00 -> $775.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 10/10/2024 |
COST Costco Wholesale | $964.01
+0.9% | 10/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $955.00 -> $980.00 | Medium | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 10/10/2024 |
OKUR OnKure Therapeutics | $15.55
-2.8% | 10/10/2024 | Initiated by | Oppenheimer | - | Outperform | $35.00 | Medium | View details for Oppenheimer rating of OnKure Therapeutics (NASDAQ:OKUR) on 10/10/2024 |
IMVT Immunovant | $26.87
+1.2% | 10/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $47.00 -> $53.00 | Low | View details for Oppenheimer rating of Immunovant (NASDAQ:IMVT) on 10/9/2024 |
TSLA Tesla | $352.56
+3.8% | 10/8/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 10/8/2024 |
EFX Equifax | $253.58
+0.4% | 10/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $315.00 | Low | View details for Oppenheimer rating of Equifax (NYSE:EFX) on 10/8/2024 |
FICO Fair Isaac | $2,356.34
+0.8% | 10/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $1,967.00 -> $2,109.00 | Low | View details for Oppenheimer rating of Fair Isaac (NYSE:FICO) on 10/8/2024 |
